Which company was first to receive FDA approval for a CRISPR-based therapy for human use in the United States?

In the world of scientific product launches, timing and positioning are everything. The CRISPR gene-editing technology represents one of the most significant scientific breakthroughs of the 21st century, quickly moving from laboratory discovery to commercialized products. This poll tests your knowledge about how this groundbreaking technology transitioned from academic research to commercial product launches in the biotechnology sector.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

CRISPR Therapeutics and Vertex Pharmaceuticals (for Casgevy)
Intellia Therapeutics (for NTLA-2001)
Editas Medicine (for EDIT-101)
Beam Therapeutics (for BEAM-101)